[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 144:  The drug Acalabrutinib (CALQUENCE), with RXCUI 1986808, is indicated for Mantle cell lymphoma and Chronic lymphocytic leukaemia, corresponding to MONDO IDs MONDO:0018876 and MONDO:0004948 and UMLS CUI IDs C0334634 and C0023434 respectively.  This row shows a drug with specific indications for two types of lymphoma.\n\nRow 140: The drug entry for RXCUI 6387 lists multiple brand names (ASPERCREME WITH LIDOCAINE, EMLA, GLYDO, Lidocaine Injection, LIDODERM, ORAQIX, SOLARCAINE, XYLOCAINE, ZINGO) but lacks specified indications, MONDO IDs, and UMLS CUIs. This row highlights a drug with many brand names but missing crucial clinical information.\n\nRow 143: The drug KEVZARA (SARILUMAB), with RXCUI 1923319, is indicated for Rheumatoid arthritis, which corresponds to MONDO ID MONDO:0008383 and UMLS CUI C0003873. This row represents a drug specifically indicated for treating rheumatoid arthritis.\n\nRow 141: The drug Gemtuzumab ozogamicin (MYLOTARG), with RXCUI 1294580, is indicated for Acute myeloid leukaemia, corresponding to MONDO ID MONDO:0018874 and UMLS CUI C0023467. This row shows a drug specifically indicated for a type of leukemia.\n\nRow 142: The drug Thioguanine (TABLOID, TIOGUANINE), with RXCUI 10485, is indicated for Acute lymphocytic leukaemia, corresponding to MONDO ID MONDO:0013108 and UMLS CUI C0023449. This row shows a drug specifically indicated for another type of leukemia."
    }
]